Weekly Features

The continued exploration of modernizing clinical trials

Monday, May 1, 2017

The need for an alternative to the paper-based clinical trial process is long overdue. Not only is the original method cost- and labor-intensive, but it can delay new drug development, as well. The first siteless technology model for clinical trial research was introduced last year, and since then studies in this area continue.

[Read More]

Shirley Ryan AbilityLab launches to move scientific research from bench to bedside

Monday, April 17, 2017

The Rehabilitation Institute of Chicago (RIC) has moved into a new research hospital facility and renamed itself the Shirley Ryan AbilityLab. The former RIC now occupies a $550 million, 1.2 million square foot facility located on prime real estate in downtown Chicago. The AbilityLab aims to create a setting in which research scientists, engineers and other specialists can work side-by-side with clinicians and patients to improve treatment. This approach is a departure from traditional methods of organizing clinical practice and research, and will serve as an experimental model for medical institutions to observe.

[Read More]

Bridging the gap: Incorporating research into care

Monday, April 10, 2017

A few years ago, the idea that primary care physicians might offer clinical trials as a routine part of care seemed far-fetched. But today, a growing body of evidence supports the notion that integrating research into clinical care can improve efficiencies, bolster patient engagement and reduce cost.

[Read More]

Parexel brings a new patient sensor platform to market

Monday, April 10, 2017

Parexel International, a global biopharmaceutical service provider based in Boston, recently launched Perceptive My Trials Analytics Platform, a tool designed to securely collect and store data from patients wearing medical devices and participating in clinical trials. The system has the capacity to collect data from six wearable devices or sensors measuring lung capacity, pulse, blood glucose levels, body weight and activity levels—essential information for many trials.

[Read More]